BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23953137)

  • 1. A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene.
    An J; Nakajima T; Shibata H; Arimura T; Yasunami M; Kimura A
    J Autoimmun; 2013 Dec; 47():25-33. PubMed ID: 23953137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
    Shih SR; Krug RM
    EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of influenza A virus mRNA splicing by CLK1.
    Artarini A; Meyer M; Shin YJ; Huber K; Hilz N; Bracher F; Eros D; Orfi L; Keri G; Goedert S; Neuenschwander M; von Kries J; Domovich-Eisenberg Y; Dekel N; Szabadkai I; Lebendiker M; Horváth Z; Danieli T; Livnah O; Moncorgé O; Frise R; Barclay W; Meyer TF; Karlas A
    Antiviral Res; 2019 Aug; 168():187-196. PubMed ID: 31176694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
    Robard C; Daviau A; Di Fruscio M
    Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
    Blanco FJ; Bernabeu C
    Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
    Gonçalves V; Matos P; Jordan P
    Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a chemical inhibitor for nuclear speckle formation: implications for the function of nuclear speckles in regulation of alternative pre-mRNA splicing.
    Kurogi Y; Matsuo Y; Mihara Y; Yagi H; Shigaki-Miyamoto K; Toyota S; Azuma Y; Igarashi M; Tani T
    Biochem Biophys Res Commun; 2014 Mar; 446(1):119-24. PubMed ID: 24569078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.
    Duncan PI; Stojdl DF; Marius RM; Bell JC
    Mol Cell Biol; 1997 Oct; 17(10):5996-6001. PubMed ID: 9315658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XE7: a novel splicing factor that interacts with ASF/SF2 and ZNF265.
    Mangs AH; Speirs HJ; Goy C; Adams DJ; Markus MA; Morris BJ
    Nucleic Acids Res; 2006; 34(17):4976-86. PubMed ID: 16982639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
    Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
    BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
    Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
    Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
    Lemaire R; Winne A; Sarkissian M; Lafyatis R
    Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
    Gao H; Gordon-Kamm WJ; Lyznik LA
    Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
    Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
    EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
    Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
    J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct bipartite motif is required for the localization of inhibitory kappaB-like (IkappaBL) protein to nuclear speckles.
    Semple JI; Brown SE; Sanderson CM; Campbell RD
    Biochem J; 2002 Feb; 361(Pt 3):489-96. PubMed ID: 11802778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.